Bioline Rx Ltd Adr (BLRX)

Nov 19, 2025

BioLineRx stock rises after partner receives key patent allowance - Investing.com

Nov 19, 2025

Nov 17, 2025

BioLineRx stock rises after securing key patent for cancer treatment - Investing.com India

Nov 17, 2025

Nov 17, 2025

BioLineRx Announces Receipt of USPTO Notice of Allowance for Key Patent Covering GLIX1 for Treating a Broad Range of Cancer Types - Finviz

Nov 17, 2025

Nov 17, 2025

BioLineRx Secures USPTO Patent Allowance for Cancer Treatment with GLIX1 - TipRanks

Nov 17, 2025

Nov 17, 2025

BioLineRx receives key patent for cancer treatment GLIX1 - Investing.com India

Nov 17, 2025

Nov 17, 2025

BioLineRx receives key patent for cancer treatment GLIX1 By Investing.com - Investing.com South Africa

Nov 17, 2025

Nov 15, 2025

Analysts’ Top Healthcare Picks: Serina Therapeutics (SER), Cybin (CYBN) - The Globe and Mail

Nov 15, 2025

Nov 12, 2025

Analysts Are Bullish on These Healthcare Stocks: Beyond Air (XAIR), Diamedica Therapeutics (DMAC) - The Globe and Mail

Nov 12, 2025

Nov 07, 2025

Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Lexicon Pharmaceuticals (LXRX) and Cullinan Management (CGEM) - The Globe and Mail

Nov 07, 2025

Nov 03, 2025

Working capital per share of BioLineRX Ltd. Sponsored ADR – SWB:YP2 - TradingView

Nov 03, 2025

Nov 02, 2025

BioLineRx ADR Earnings Call: Optimism Amid Challenges - MSN

Nov 02, 2025

Oct 18, 2025

Analysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), Achieve Life Sciences (ACHV) - The Globe and Mail

Oct 18, 2025

Oct 16, 2025

Cash per share of BioLineRX Ltd. Sponsored ADR – FWB:YP2 - TradingView

Oct 16, 2025

Sep 29, 2025

BioLineRx, Hemispherian AS establish joint venture to develop GLIX1 - TipRanks

Sep 29, 2025

Sep 29, 2025

BioLineRx and Hemispherian Launch Joint Venture to Develop GLIX1 for Glioblastoma - TipRanks

Sep 29, 2025

Sep 29, 2025

BioLineRx and Hemispherian form joint venture to develop brain cancer drug - Investing.com

Sep 29, 2025

Sep 29, 2025

BioLineRx Ltd. and Hemispherian AS Establish Joint Venture to Develop GLIX1, a First-in-Class, Oral, Small Molecule Targeting DNA Damage Response in Glioblastoma and Other Cancers - Sahm

Sep 29, 2025

Sep 20, 2025

BioLineRx (NASDAQ:BLRX) Stock Passes Above Two Hundred Day Moving Average – What’s Next? - Defense World

Sep 20, 2025

Aug 21, 2025

Earnings call transcript: BioLineRx Q2 2025 sees restructuring and innovation - Investing.com

Aug 21, 2025

Aug 15, 2025

BioLineRx: Strategic Pipeline Expansion and Strong Financial Health Justify Buy Rating - TipRanks

Aug 15, 2025

Aug 15, 2025

BioLineRx Ltd. Reports Q2 2025 Financial Results - TipRanks

Aug 15, 2025

Aug 14, 2025

BioLineRx Reports Q2 2025 Financials and Strategic Updates - MSN

Aug 14, 2025

Aug 14, 2025

BioLineRx To Report Second Quarter 2025 Results On August 14, 2025 - Barchart.com

Aug 14, 2025

Aug 14, 2025

BioLineRx: Promising Financial Position and Strategic Initiatives Drive Buy Rating - TipRanks

Aug 14, 2025

Aug 14, 2025

BioLineRx Reports Second Quarter 2025 Financial Results And Provides Corporate Update - Barchart.com

Aug 14, 2025

Aug 09, 2025

Analysts Offer Insights on Healthcare Companies: Avalo Therapeutics (AVTX), Iovance Biotherapeutics (IOVA) and NextCure (NXTC) - The Globe and Mail

Aug 09, 2025

Jul 25, 2025

Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX) and Gilead Sciences (GILD) - The Globe and Mail

Jul 25, 2025

Jul 09, 2025

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Esperion (ESPR) - The Globe and Mail

Jul 09, 2025

Jul 06, 2025

Analysts Offer Insights on Healthcare Companies: NextCure (NXTC), Lexaria Bioscience (LEXX) and Travere Therapeutics (TVTX) - The Globe and Mail

Jul 06, 2025

Jul 01, 2025

Analysts Offer Insights on Healthcare Companies: Aytu BioScience (AYTU), Processa Pharmaceuticals (PCSA) and Clene (CLNN) - The Globe and Mail

Jul 01, 2025

Jun 30, 2025

BioLineRx Ltd. Approves Key Proposals at Annual Meeting - TipRanks

Jun 30, 2025

Jun 24, 2025

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Capricor Therapeutics (CAPR) and Abbott Laboratories (ABT) - The Globe and Mail

Jun 24, 2025

Jun 17, 2025

Promising Phase 2 Trial Results Drive Buy Rating for BioLine RX in mPDAC Treatment - TipRanks

Jun 17, 2025

Jun 04, 2025

BioLineRx ADR: Positive Earnings Call Highlights and Challenges - MSN

Jun 04, 2025

Jun 04, 2025

Analysts Offer Insights on NA Companies: Tempus AI, Inc. Class A (TEM) and Rapport Therapeutics, Inc. (RAPP) - The Globe and Mail

Jun 04, 2025

May 31, 2025

BioLineRx upgraded to Buy from Hold at JonesResearch - Yahoo Finance

May 31, 2025

May 31, 2025

BioLineRx reports promising pancreatic cancer trial data By Investing.com - Investing.com South Africa

May 31, 2025

May 30, 2025

BioLineRx Stock Jumps On Positive Data from Pilot Phase Of Pancreatic Cancer Drug Trial: Retail Cheers The ‘Buy’ Rating By Stocktwits - Investing.com India

May 30, 2025

May 30, 2025

BioLineRx announces new data from Phase 2 combination trial of motixafortide - TipRanks

May 30, 2025

May 30, 2025

Jones Trading raises BioLineRx stock rating, targets $12 By Investing.com - Investing.com South Africa

May 30, 2025

May 30, 2025

Jones Trading raises BioLineRx stock rating, targets $12 - Investing.com India

May 30, 2025

May 30, 2025

BioLineRx Presents Promising Phase 2 Data at ASCO 2025 for Pancreatic Cancer Trial - TipRanks

May 30, 2025

May 30, 2025

BioLineRx reports promising pancreatic cancer trial data - Investing.com

May 30, 2025

May 29, 2025

JonesTrading Reaffirms Their Hold Rating on Bioline RX Ltd Sponsored ADR (BLRX) - The Globe and Mail

May 29, 2025

May 28, 2025

Jones Trading maintains Hold on BioLineRx stock amid royalty prospects - Investing.com India

May 28, 2025

May 28, 2025

Jones Trading maintains Hold on BioLineRx stock amid royalty prospects By Investing.com - Investing.com South Africa

May 28, 2025

May 28, 2025

H.C. Wainwright Maintains Buy Rating, $26 Target on BioLineRx Stock - Investing.com

May 28, 2025